General Information of the Compound
Compound ID
CP0505240
Compound Name
N-[1-[(3,5-dimethoxyphenyl)methyl]piperidin-3-yl]-1H-indazol-5-amine
    Show/Hide
Structure
Formula
C21H26N4O2
Molecular Weight
366.465
Canonical SMILES
COc1cc(CN2CCCC(C2)Nc2ccc3[nH]ncc3c2)cc(OC)c1
    Show/Hide
InChI
InChI=1S/C21H26N4O2/c1-26-19-8-15(9-20(11-19)27-2)13-25-7-3-4-18(14-25)23-17-5-6-21-16(10-17)12-22-24-21/h5-6,8-12,18,23H,3-4,7,13-14H2,1-2H3,(H,22,24)
    Show/Hide
InChIKey
QRVGBTGBMIUBQJ-UHFFFAOYSA-N
Physicochemical Property
logP
3.6566
Rotatable Bonds
6
Heavy Atom Count
27
Polar Areas
62.41
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21098475
ChEMBL ID
CHEMBL389622
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01021, C-C chemokine receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000100 U-937 Homo sapiens (Human)  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS